Literature DB >> 11319856

Integrin receptors are required for cell survival and proliferation during development of the peripheral glial lineage.

H Haack1, R O Hynes.   

Abstract

Proliferation and survival of Schwann cells are important for nerve development and for disease processes in peripheral nerves. We have analyzed embryos lacking alpha4- or alpha5-integrins and show here that these integrins contribute to the control of glial cell numbers. To overcome early embryonic lethality an explant and grafting system that allows the study of isolated glial progenitor cells both in vitro and in vivo was used. Schwann cells differentiate in the absence of alpha5 but their numbers and the proliferation rate of early progenitor cells are reduced, suggesting that alpha5 is essential for normal proliferation. Survival, rather than proliferation, is compromised in alpha4-deficient explants. Conditional immortalization allowed further characterization and revealed that alpha4 contributes to survival in a cell-density-dependent fashion. In addition, transplants into chicken embryos were used to analyze in vivo cell migration and showed that cell death occurs mainly in highly motile, individually migrating cells. The cell death patterns in vitro and in vivo argue that alpha4-integrins play a role in survival during cell migration. Neural crest migration has been suggested to require these integrins; however, no defects in migration were observed in the absence of alpha4 or alpha5. We conclude that integrins can complement growth factors in the control of glial cell numbers. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319856     DOI: 10.1006/dbio.2001.0213

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  16 in total

1.  Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells.

Authors:  Johanna Buchstaller; Lukas Sommer; Matthias Bodmer; Reinhard Hoffmann; Ueli Suter; Ned Mantei
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 2.  In the beginning: Generating neural crest cell diversity.

Authors:  Christiana Ruhrberg; Quenten Schwarz
Journal:  Cell Adh Migr       Date:  2010 Oct-Dec       Impact factor: 3.405

3.  Fibronectin signals through integrin α5β1 to regulate cardiovascular development in a cell type-specific manner.

Authors:  Dongying Chen; Xia Wang; Dong Liang; Julie Gordon; Ashok Mittal; Nancy Manley; Karl Degenhardt; Sophie Astrof
Journal:  Dev Biol       Date:  2015-10-03       Impact factor: 3.582

Review 4.  Division of labor during trunk neural crest development.

Authors:  Laura S Gammill; Julaine Roffers-Agarwal
Journal:  Dev Biol       Date:  2010-04-24       Impact factor: 3.582

5.  Nerve Guidance by a Decellularized Fibroblast Extracellular Matrix.

Authors:  Greg M Harris; Nicolas N Madigan; Karen Z Lancaster; Lynn W Enquist; Anthony J Windebank; Jeffrey Schwartz; Jean E Schwarzbauer
Journal:  Matrix Biol       Date:  2016-09-15       Impact factor: 11.583

Review 6.  Integrins as receptor targets for neurological disorders.

Authors:  Xin Wu; Doodipala Samba Reddy
Journal:  Pharmacol Ther       Date:  2011-12-30       Impact factor: 12.310

7.  Fibronectin and integrin alpha 5 play essential roles in the development of the cardiac neural crest.

Authors:  Ashok Mittal; Maria Pulina; Shuan-Yu Hou; Sophie Astrof
Journal:  Mech Dev       Date:  2010-08-31       Impact factor: 1.882

Review 8.  Studies on integrins in the nervous system.

Authors:  Sumiko Denda; Louis F Reichardt
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

9.  Neural crest cell-autonomous roles of fibronectin in cardiovascular development.

Authors:  Xia Wang; Sophie Astrof
Journal:  Development       Date:  2015-11-09       Impact factor: 6.868

Review 10.  Role of integrins in peripheral nerves and hereditary neuropathies.

Authors:  Caterina Berti; Alessandro Nodari; Lawrence Wrabetz; Maria Laura Feltri
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.